JP2025148449A5 - - Google Patents
Info
- Publication number
- JP2025148449A5 JP2025148449A5 JP2025116307A JP2025116307A JP2025148449A5 JP 2025148449 A5 JP2025148449 A5 JP 2025148449A5 JP 2025116307 A JP2025116307 A JP 2025116307A JP 2025116307 A JP2025116307 A JP 2025116307A JP 2025148449 A5 JP2025148449 A5 JP 2025148449A5
- Authority
- JP
- Japan
- Prior art keywords
- weeks
- patient
- dose
- administered
- mirikizumab
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962836910P | 2019-04-22 | 2019-04-22 | |
| US62/836,910 | 2019-04-22 | ||
| JP2021562882A JP7297930B2 (ja) | 2019-04-22 | 2020-04-15 | クローン病を治療する方法に使用するためのミリキズマブ |
| PCT/US2020/028273 WO2020219314A1 (en) | 2019-04-22 | 2020-04-15 | Mirikizumab for use in a method of treating crohn's disease |
| JP2023097427A JP7761614B2 (ja) | 2019-04-22 | 2023-06-14 | クローン病を治療する方法に使用するためのミリキズマブ |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023097427A Division JP7761614B2 (ja) | 2019-04-22 | 2023-06-14 | クローン病を治療する方法に使用するためのミリキズマブ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025148449A JP2025148449A (ja) | 2025-10-07 |
| JP2025148449A5 true JP2025148449A5 (enExample) | 2026-01-20 |
Family
ID=70554215
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562882A Active JP7297930B2 (ja) | 2019-04-22 | 2020-04-15 | クローン病を治療する方法に使用するためのミリキズマブ |
| JP2023097427A Active JP7761614B2 (ja) | 2019-04-22 | 2023-06-14 | クローン病を治療する方法に使用するためのミリキズマブ |
| JP2025116307A Pending JP2025148449A (ja) | 2019-04-22 | 2025-07-10 | クローン病を治療する方法に使用するためのミリキズマブ |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562882A Active JP7297930B2 (ja) | 2019-04-22 | 2020-04-15 | クローン病を治療する方法に使用するためのミリキズマブ |
| JP2023097427A Active JP7761614B2 (ja) | 2019-04-22 | 2023-06-14 | クローン病を治療する方法に使用するためのミリキズマブ |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20220040299A1 (enExample) |
| EP (1) | EP3958897A1 (enExample) |
| JP (3) | JP7297930B2 (enExample) |
| KR (2) | KR20250153865A (enExample) |
| CN (2) | CN119700968A (enExample) |
| AU (2) | AU2020263238C1 (enExample) |
| BR (1) | BR112021018930A2 (enExample) |
| CA (1) | CA3134587A1 (enExample) |
| EA (1) | EA202192532A1 (enExample) |
| IL (2) | IL286818B1 (enExample) |
| MA (1) | MA55756A (enExample) |
| MX (1) | MX2021012848A (enExample) |
| SG (1) | SG11202110619XA (enExample) |
| TW (2) | TWI850365B (enExample) |
| UA (1) | UA128657C2 (enExample) |
| WO (1) | WO2020219314A1 (enExample) |
| ZA (1) | ZA202108094B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI850365B (zh) * | 2019-04-22 | 2024-08-01 | 美商美國禮來大藥廠 | 治療克隆氏症(crohn's disease)的方法 |
| KR20220066831A (ko) | 2020-11-16 | 2022-05-24 | 엔브이에이치코리아(주) | 습기경화형 접착제를 이용한 헤드라이닝 제조방법 및 이에 의해 제조되는 헤드라이닝 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20140049B1 (ar) | 2013-03-08 | 2021-08-17 | Lilly Co Eli | أجسام مضادة ترتبط بـ il-23 |
| EP3693007A1 (en) | 2013-03-15 | 2020-08-12 | Amgen, Inc | Methods for treating crohn's disease using an anti-il23 antibody |
| TWI811716B (zh) * | 2015-09-18 | 2023-08-11 | 德商百靈佳殷格翰國際股份有限公司 | 治療發炎性疾病之方法 |
| AU2017312049A1 (en) * | 2016-08-19 | 2019-02-21 | Janssen Biotech, Inc. | Methods of treating Crohn's Disease with an anti-NKG2D antibody |
| KR20200037258A (ko) * | 2017-07-10 | 2020-04-08 | 람밤 메드-테크 엘티디. | 생물학적 약물로 치료받은 피험자에서 중화 항체 수준 평가용 분석법 및 맞춤 의료에서 이의 사용 |
| TWI850365B (zh) * | 2019-04-22 | 2024-08-01 | 美商美國禮來大藥廠 | 治療克隆氏症(crohn's disease)的方法 |
-
2020
- 2020-04-14 TW TW109112447A patent/TWI850365B/zh active
- 2020-04-14 TW TW113124301A patent/TW202515610A/zh unknown
- 2020-04-15 UA UAA202105413A patent/UA128657C2/uk unknown
- 2020-04-15 WO PCT/US2020/028273 patent/WO2020219314A1/en not_active Ceased
- 2020-04-15 AU AU2020263238A patent/AU2020263238C1/en active Active
- 2020-04-15 JP JP2021562882A patent/JP7297930B2/ja active Active
- 2020-04-15 CN CN202411949868.6A patent/CN119700968A/zh active Pending
- 2020-04-15 MA MA055756A patent/MA55756A/fr unknown
- 2020-04-15 CN CN202080030747.5A patent/CN113677366A/zh active Pending
- 2020-04-15 MX MX2021012848A patent/MX2021012848A/es unknown
- 2020-04-15 KR KR1020257033226A patent/KR20250153865A/ko active Pending
- 2020-04-15 EA EA202192532A patent/EA202192532A1/ru unknown
- 2020-04-15 SG SG11202110619XA patent/SG11202110619XA/en unknown
- 2020-04-15 KR KR1020217034113A patent/KR102869852B1/ko active Active
- 2020-04-15 CA CA3134587A patent/CA3134587A1/en active Pending
- 2020-04-15 BR BR112021018930A patent/BR112021018930A2/pt unknown
- 2020-04-15 EP EP20724301.5A patent/EP3958897A1/en active Pending
-
2021
- 2021-09-29 IL IL286818A patent/IL286818B1/en unknown
- 2021-10-21 ZA ZA2021/08094A patent/ZA202108094B/en unknown
- 2021-10-21 US US17/507,414 patent/US20220040299A1/en active Pending
-
2023
- 2023-06-14 JP JP2023097427A patent/JP7761614B2/ja active Active
- 2023-11-13 AU AU2023265759A patent/AU2023265759A1/en active Pending
-
2025
- 2025-07-10 JP JP2025116307A patent/JP2025148449A/ja active Pending
- 2025-10-19 IL IL324048A patent/IL324048A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025020134A5 (enExample) | ||
| JP2023166388A5 (enExample) | ||
| JP2025148449A5 (enExample) | ||
| Aho et al. | The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy | |
| JP2005520778A5 (enExample) | ||
| IL299376A (en) | Fixed dose combination of pertuzumab plus transtuzumab | |
| JP2013533858A5 (enExample) | ||
| KR101900520B1 (ko) | 복합 조성물 | |
| JP2014515373A5 (enExample) | ||
| JP2020509024A5 (enExample) | ||
| NZ598534A (en) | Dosage regimen of an s1p receptor modulator | |
| JP2018526460A5 (enExample) | ||
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2017510607A5 (enExample) | ||
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| KR20120138229A (ko) | 정맥내 투여용 이부프로펜을 이용한 중증 환자의 치료 | |
| CN109172550B (zh) | 一种复合麻醉药物 | |
| CN108014337B (zh) | 一种用于治疗眼自身免疫性葡萄膜炎的药物组合物 | |
| CN110841069A (zh) | 一种含有沙利度胺与抗真菌药物的药物组合物及应用 | |
| NZ781127B2 (en) | Mirikizumab for use in a method of treating crohn's disease | |
| NZ767902B2 (en) | Methods of treating ulcerative colitis | |
| SU429813A1 (ru) | Способ лечения туберкулеза легких | |
| JP2016510738A5 (enExample) | ||
| WO2019241495A1 (en) | Pharmaceutical composition and method for acute on chronic liver failure | |
| RU2233664C2 (ru) | Способ лечения красного плоского лишая |